Offerings // Faeth Therapeutics, Inc.

FTH offering history

Every offering-related filing in Faeth Therapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 454 filings back to Nov 12, 2020.

Last executed offering

Feb 18, 2026

8-K — priced deal (shares or notes)

Last registration (announced)

Jun 18, 2026

S-3ASR — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Jun 18, 2026	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
Jun 12, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 10, 2026	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Jun 2, 2026	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Apr 28, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Feb 18, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Aug 17, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 9, 2022	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
May 9, 2022	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 9, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 15, 2022	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Feb 4, 2021	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Feb 3, 2021	S-1MEF →	REGISTERED	S-1MEF registration — capacity to sell shares, not a sale yet
Feb 3, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Feb 1, 2021	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jan 15, 2021	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet

FTH offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full FTH workspace →

FTH offering FAQ

When did FTH last execute an offering?

Per SEC filings, Faeth Therapeutics, Inc.'s most recent priced offering document is a 8-K filed 2026-02-18. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did FTH last announce or register an offering?

The most recent registration is a S-3ASR filed 2026-06-18. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.